Title:
子癇前症の検出を補助する方法またはそのリスクの推定を補助する方法
Document Type and Number:
Japanese Patent JP5819285
Kind Code:
B2
Abstract:
The invention relates to a novel cell derived from the human body, where said cell comprises a Clever-1 receptor; to a method for affecting the immune system of an individual and for treatment of diseases or conditions related to the function of the immune system and to methods for screening of cancer patients that may respond to an anti-Clever-1 therapy or for diagnosing of a pregnancy complication or for estimating the risk of such complication in a pregnant woman.
Inventors:
Yarkanen, Silpa
Salmi, marco
Yarkanen, Mark
Salmi, marco
Yarkanen, Mark
Application Number:
JP2012506538A
Publication Date:
November 24, 2015
Filing Date:
April 06, 2010
Export Citation:
Assignee:
Fallon Pharmaceuticals Osamu Yukiture
International Classes:
C12Q1/68; G01N33/68
Domestic Patent References:
| JP2005523247A |
Other References:
The Journal of Immunology,2008年,Vol.180,pp.3028-3037
Eur. J. Immunol.,2011年,Vol.41,pp.2052-2063
Eur. J. Immunol.,2011年,Vol.41,pp.2052-2063
Attorney, Agent or Firm:
Asahina Patent Office